Activated CD69 + T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1117-1124

  Zhao, Qiyi ^a   Kuang, Dong Ming ^a   Wu, Yan ^a   Xiao, Xiao ^a   Li, Xue Feng ^a   Li, Tuan Jie ^a   Zheng, Limin ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 12; TRYPTOPHAN;

ARTICLE; CD69+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CARCINOMA, HEPATOCELLULAR; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MACROPHAGES; T-LYMPHOCYTES; TRYPTOPHAN;

EID: 84863012436     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100164     Document Type: Article

References (45)

1. Mueller, M. M., and N. E. Fusenig. 2004. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4: 839-849. (Pubitemid 39472951)
2. Tlsty, T. D., and L. M. Coussens. 2006. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1: 119-150.
3. Kuang, D. M., Q. Zhao, Y. Wu, C. Peng, J. Wang, Z. Xu, X. Y. Yin, and L. Zheng. 2011. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J. Hepatol. 54: 948-955.
4. Murdoch, C., M. Muthana, S. B. Coffelt, and C. E. Lewis. 2008. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8: 618-631.
5. Kuang, D. M., C. Peng, Q. Zhao, Y. Wu, M. S. Chen, and L. Zheng. 2010. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 51: 154-164.
6. DeNardo, D. G., J. B. Barreto, P. Andreu, L. Vasquez, D. Tawfik, N. Kolhatkar, and L. M. Coussens. 2009. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16: 91-102.
7. Kryczek, I., S. Wei, L. Zou, G. Zhu, P. Mottram, H. Xu, L. Chen, and W. Zou. 2006. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J. Immunol. 177: 40-44. (Pubitemid 43939113)
8. Zhang, J. Y., Z. Zhang, F. Lin, Z. S. Zou, R. N. Xu, L. Jin, J. L. Fu, F. Shi, M. Shi, H. F. Wang, and F. S. Wang. 2010. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51: 81-91.
9. Kim, K. D., J. Zhao, S. Auh, X. Yang, P. Du, H. Tang, and Y. X. Fu. 2007. Adaptive immune cells temper initial innate responses. Nat. Med. 13: 1248-1252. (Pubitemid 47530627)
10. Zhao, J., X. Yang, S. L. Auh, K. D. Kim, H. Tang, and Y. X. Fu. 2009. Do adaptive immune cells suppress or activate innate immunity? Trends Immunol. 30: 8-12.
11. Pollard, J. W. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4: 71-78. (Pubitemid 38082155)
12. Qian, B. Z., and J. W. Pollard. 2010. Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
13. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964. (Pubitemid 41746764)
14. Kuang, D. M., Y. Wu, N. Chen, J. Cheng, S. M. Zhuang, and L. Zheng. 2007. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 110: 587-595. (Pubitemid 47105397)
15. Kuang, D. M., Q. Zhao, C. Peng, J. Xu, J. P. Zhang, C. Wu, and L. Zheng. 2009. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med. 206: 1327-1337.
16. Zhao, Q., X. Xiao, Y. Wu, Y. Wei, L. Y. Zhu, J. Zhou, and D. M. Kuang. 2011. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients. Eur. J. Immunol. 41: 2314-2322.
17. Sancho, D., M. Gómez, and F. Sánchez-Madrid. 2005. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 26: 136-140. (Pubitemid 40312520)
18. Wald, O., U. Izhar, G. Amir, S. Avniel, Y. Bar-Shavit, H. Wald, I. D. Weiss, E. Galun, and A. Peled. 2006. CD4+CXCR4highCD69+ T cells accumulate in lung adenocarcinoma. J. Immunol. 177: 6983-6990.
19. Han, Y., Q. Guo, M. Zhang, Z. Chen, and X. Cao. 2009. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J. Immunol. 182: 111-120.
20. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774. (Pubitemid 39336293)
21. Terness, P., J. J. Chuang, and G. Opelz. 2006. The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends Immunol. 27: 68-73. (Pubitemid 43221972)
22. Uyttenhove, C., L. Pilotte, I. Théate, V. Stroobant, D. Colau, N. Parmentier, T. Boon, and B. J. Van den Eynde. 2003. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9: 1269-1274. (Pubitemid 37279849)
23. Liu, L., L. Duan, M. Gong, H. Dai, Q. Gong, F. Zheng, Z. Tan, C. Wang, F. Gong, and M. Fang. 2011. Indoleamine 2,3-dioxygenase and regulatory dendritic cells contribute to the allograft protection induced by infusion of donorspecific splenic stromal cells. Cell. Mol. Immunol. 8: 31-40.
24. Romani, L., F. Fallarino, A. De Luca, C. Montagnoli, C. D'Angelo, T. Zelante, C. Vacca, F. Bistoni, M. C. Fioretti, U. Grohmann, et al. 2008. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
25. Godin-Ethier, J., S. Pelletier, L. A. Hanafi, P. O. Gannon, M. A. Forget, J. P. Routy, M. R. Boulassel, U. Krzemien, S. Tanguay, J. B. Lattouf, et al. 2009. Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. J. Immunol. 183: 7752-7760.
26. + regulatory T cells in cancer patients. Blood 107: 2409-2414.
27. Matin, A., I. M. Streete, I. M. Jamie, R. J. Truscott, and J. F. Jamie. 2006. A fluorescence-based assay for indoleamine 2,3-dioxygenase. Anal. Biochem. 349: 96-102. (Pubitemid 43129562)
28. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, M. Azuma, B. R. Blazar, A. L. Mellor, and D. H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117: 2570-2582. (Pubitemid 47494358)
29. Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189: 1363-1372. (Pubitemid 29227522)
30. Rabinovich, G. A., D. Gabrilovich, and E. M. Sotomayor. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25: 267-296. (Pubitemid 46697910)
31. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212. (Pubitemid 37547898)
32. Mellor, A. L., and D. H. Munn. 2008. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat. Rev. Immunol. 8: 74-80.
33. Esplugues, E., D. Sancho, J. Vega-Ramos, C. Martínez, U. Syrbe, A. Hamann, P. Engel, F. Sánchez-Madrid, and P. Lauzurica. 2003. Enhanced antitumor immunity in mice deficient in CD69. J. Exp. Med. 197: 1093-1106. (Pubitemid 36570065)
34. Sancho, D., M. Gómez, F. Viedma, E. Esplugues, M. Gordón-Alonso, M. A. García-López, H. de la Fuente, C. Martínez-A, P. Lauzurica, and F. Sánchez-Madrid. 2003. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J. Clin. Invest. 112: 872-882. (Pubitemid 38063745)
35. Zingoni, A., G. Palmieri, S. Morrone, M. Carretero, M. Lopez-Botel, M. Piccoli, L. Frati, and A. Santoni. 2000. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor. Eur. J. Immunol. 30: 644-651. (Pubitemid 30098859)
36. Kuang, D. M., C. Peng, Q. Zhao, Y. Wu, L. Y. Zhu, J.Wang, X. Y. Yin, L. Li, and L. Zheng. 2010. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J. Immunol. 185: 1544-1549.
37. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555. (Pubitemid 35223554)
38. Biswas, S. K., A. Sica, and C. E. Lewis. 2008. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 180: 2011-2017.
39. Ding, T., J. Xu, F. Wang, M. Shi, Y. Zhang, S. P. Li, and L. Zheng. 2009. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum. Pathol. 40: 381-389.
40. Gu, T., R. B. Rowswell-Turner, M. O. Kilinc, and N. K. Egilmez. 2010. Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity. Cancer Res. 70: 129-138.
41. Muller, A. J., J. B. DuHadaway, P. S. Donover, E. Sutanto-Ward, and G. C. Prendergast. 2005. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11: 312-319. (Pubitemid 40460560)
42. Subudhi, S. K., P. Zhou, L. M. Yerian, R. K. Chin, J. C. Lo, R. A. Anders, Y. Sun, L. Chen, Y. Wang, M. L. Alegre, and Y. X. Fu. 2004. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113: 694-700. (Pubitemid 38544162)
43. Zou, W., and L. Chen. 2008. Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol. 8: 467-477. (Pubitemid 351733418)
44. Wu, Y., Q. Zhao, C. Peng, L. Sun, X. F. Li, and D. M. Kuang. 2011. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J. Pathol. 225: 438-447.
45. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature 454: 436-444.